388 related articles for article (PubMed ID: 11472273)
1. Amylin replacement with pramlintide as an adjunct to insulin therapy in type 1 and type 2 diabetes mellitus: a physiological approach toward improved metabolic control.
Weyer C; Maggs DG; Young AA; Kolterman OG
Curr Pharm Des; 2001 Sep; 7(14):1353-73. PubMed ID: 11472273
[TBL] [Abstract][Full Text] [Related]
2. Unresolved challenges with insulin therapy in type 1 and type 2 diabetes: potential benefit of replacing amylin, a second beta-cell hormone.
Edelman SV; Weyer C
Diabetes Technol Ther; 2002; 4(2):175-89. PubMed ID: 12079621
[TBL] [Abstract][Full Text] [Related]
3. Pramlintide acetate injection for the treatment of type 1 and type 2 diabetes mellitus.
Singh-Franco D; Robles G; Gazze D
Clin Ther; 2007 Apr; 29(4):535-62. PubMed ID: 17617279
[TBL] [Abstract][Full Text] [Related]
4. Role of Amylin in Type 1 and Type 2 Diabetes.
Hieronymus L; Griffin S
Diabetes Educ; 2015 Dec; 41(1 Suppl):47S-56S. PubMed ID: 26424675
[TBL] [Abstract][Full Text] [Related]
5. Amylin receptor agonists: a novel pharmacological approach in the management of insulin-treated diabetes mellitus.
Nyholm B; Brock B; Ørskov L; Schmitz O
Expert Opin Investig Drugs; 2001 Sep; 10(9):1641-52. PubMed ID: 11772274
[TBL] [Abstract][Full Text] [Related]
6. Clinical studies.
Young A
Adv Pharmacol; 2005; 52():289-320. PubMed ID: 16492555
[TBL] [Abstract][Full Text] [Related]
7. Pramlintide in the treatment of type 1 and type 2 diabetes mellitus.
Ryan GJ; Jobe LJ; Martin R
Clin Ther; 2005 Oct; 27(10):1500-12. PubMed ID: 16330288
[TBL] [Abstract][Full Text] [Related]
8. Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in Type 1 diabetes mellitus: a 1-year, randomized controlled trial.
Ratner RE; Dickey R; Fineman M; Maggs DG; Shen L; Strobel SA; Weyer C; Kolterman OG
Diabet Med; 2004 Nov; 21(11):1204-12. PubMed ID: 15498087
[TBL] [Abstract][Full Text] [Related]
9. Pramlintide acetate.
McQueen J
Am J Health Syst Pharm; 2005 Nov; 62(22):2363-72. PubMed ID: 16278328
[TBL] [Abstract][Full Text] [Related]
10. Pramlintide for the treatment of diabetes mellitus.
Kleppinger EL; Vivian EM
Ann Pharmacother; 2003; 37(7-8):1082-9. PubMed ID: 12841822
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of glucagon secretion.
Young A
Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
[TBL] [Abstract][Full Text] [Related]
12. The human amylin analog, pramlintide, corrects postprandial hyperglucagonemia in patients with type 1 diabetes.
Fineman MS; Koda JE; Shen LZ; Strobel SA; Maggs DG; Weyer C; Kolterman OG
Metabolism; 2002 May; 51(5):636-41. PubMed ID: 11979398
[TBL] [Abstract][Full Text] [Related]
13. Pramlintide in the treatment of diabetes mellitus.
Edelman S; Maier H; Wilhelm K
BioDrugs; 2008; 22(6):375-86. PubMed ID: 18998755
[TBL] [Abstract][Full Text] [Related]
14. Use of pramlintide: the patient's perspective.
Want L
Diabetes Educ; 2006; 32 Suppl 3():111S-118S. PubMed ID: 16751352
[TBL] [Abstract][Full Text] [Related]
15. Pramlintide in the treatment of diabetes.
Edelman SV; Darsow T; Frias JP
Int J Clin Pract; 2006 Dec; 60(12):1647-53. PubMed ID: 17109671
[TBL] [Abstract][Full Text] [Related]
16. Novel peptides under development for the treatment of type 1 and type 2 diabetes mellitus.
Baron AD; Kim D; Weyer C
Curr Drug Targets Immune Endocr Metabol Disord; 2002 Apr; 2(1):63-82. PubMed ID: 12477297
[TBL] [Abstract][Full Text] [Related]
17. Pramlintide: (AC 137, AC 0137, Symlin, Tripro-Amylin).
BioDrugs; 2003; 17(1):73-9. PubMed ID: 12534323
[TBL] [Abstract][Full Text] [Related]
18. Optimizing diabetes treatment using an amylin analogue.
Edelman SV
Diabetes Educ; 2008; 34 Suppl 1():4S-10S. PubMed ID: 18268000
[TBL] [Abstract][Full Text] [Related]
19. [Role of amylin in glucose homeostasis and its perspective use in diabetes management].
Otto-Buczkowska E; Mazur-Dworzecka U; Dworzecki T
Przegl Lek; 2008; 65(3):135-9. PubMed ID: 18624122
[TBL] [Abstract][Full Text] [Related]
20. Pramlintide: A new tool in diabetes management.
Want LL; Ratner RE
Curr Diab Rep; 2006 Nov; 6(5):344-9. PubMed ID: 17076994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
